Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.

Míreanna comhchosúla

• Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
  de réir: Smith, C, et al.
  Foilsithe / Cruthaithe: (2005)
• Immunodomination during peripheral vaccinia virus infection.
  de réir: Leon C W Lin, et al.
  Foilsithe / Cruthaithe: (2013-01-01)
• Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
  de réir: Sharpe, S, et al.
  Foilsithe / Cruthaithe: (2003)
• Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
  de réir: Gileadi, U, et al.
  Foilsithe / Cruthaithe: (1999)
• Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
  de réir: Caroline Staib, et al.
  Foilsithe / Cruthaithe: (2003-04-01)